HS-related quality of life (QoL) impairment includes an impact on multiple domains of psychophysical functioning among affected patients, resulting in depression, anxiety, stigmatization, fatigue and decreased overall activity (4, 5). The mean prevalence of HS in the Caucasian population is estimated as 1%, with a predominance in females (2, 3). Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent, debilitating and suppurative disease of the hair follicle, manifested by painful abscesses, fistulas and scarring lesions in the apocrine gland-bearing areas of the body, generally the axillae, inguinal and anogenital regions (1). Itch and pain have an important impact on insomnia and sleep quality in patients with hidradenitis suppurativa. Pain was a crucial factor responsible for poor sleep quality among patients with hidradenitis suppurativa its presence significantly affected subjective sleep quality, sleep duration and daytime dysfunction. The presence of both itch and pain had a significant impact on the frequency of insomnia. Mean ± standard deviation AIS and PSQI scores among patients with hidradenitis suppurativa vs. The Athens Insomnia Scale (AIS) and Pittsburgh Sleep Quality Index (PSQI) were used to evaluate a spectrum of sleep disturbances. The aim of this study was to assess the influence of itch and pain on sleep quality in 108 patients with hidradenitis suppurativa compared with 50 controls. There is a lack of data evaluating the influence of hidradenitis suppurativa-related subjective symptoms on sleep quality.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |